Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Karayama

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
The European Respiratory Journal|July 7, 2022
Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volumeAtsuki Fukada, Yuzo Suzuki, Kazutaka Mori, et al.
Respiratory Medicine and Research|October 30, 2025
Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trialFumiya Nihashi, Kazuki Furuhashi, Mitsuru Niwa, et al.
Investigational New Drugs|February 22, 2019
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinomaNorimichi Akiyama, Masato Karayama, Naoki Inui, et al.
Medical Oncology (Northwood, London, England)|June 18, 2018
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II studyKoji Nishimoto, Masato Karayama, Naoki Inui, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancerYusuke Inoue, Naoki Inui, Masato Karayama, et al.
Respirology (Carlton, Vic.)|November 12, 2020
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trialTomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2020
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective StudyYuzo Suzuki, Masato Karayama, Tomohiro Uto, et al.
BMC Pulmonary Medicine|October 3, 2021
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysisKoichi Miyashita, Masato Karayama, Yusuke Inoue, et al.
Respiratory Medicine|November 23, 2024
Factors associated with uncontrolled severe asthma in the biologic eraHideki Yasui, Kyohei Oishi, Fumiya Nihashi, et al.
Clinical Lung Cancer|November 3, 2025
Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic TherapySuguru Kojima, Yusuke Inoue, Masato Karayama, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
The European Respiratory Journal|July 7, 2022
Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volumeAtsuki Fukada, Yuzo Suzuki, Kazutaka Mori, et al.
Respiratory Medicine and Research|October 30, 2025
Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trialFumiya Nihashi, Kazuki Furuhashi, Mitsuru Niwa, et al.
Investigational New Drugs|February 22, 2019
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinomaNorimichi Akiyama, Masato Karayama, Naoki Inui, et al.
Medical Oncology (Northwood, London, England)|June 18, 2018
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II studyKoji Nishimoto, Masato Karayama, Naoki Inui, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancerYusuke Inoue, Naoki Inui, Masato Karayama, et al.
Respirology (Carlton, Vic.)|November 12, 2020
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trialTomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2020
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective StudyYuzo Suzuki, Masato Karayama, Tomohiro Uto, et al.
BMC Pulmonary Medicine|October 3, 2021
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysisKoichi Miyashita, Masato Karayama, Yusuke Inoue, et al.
Respiratory Medicine|November 23, 2024
Factors associated with uncontrolled severe asthma in the biologic eraHideki Yasui, Kyohei Oishi, Fumiya Nihashi, et al.
Clinical Lung Cancer|November 3, 2025
Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic TherapySuguru Kojima, Yusuke Inoue, Masato Karayama, et al.
Pageof 20